Fermentalg's Q1 2026 Sees Record Turnover Amid Strategic Shifts

In the first quarter of 2026, Fermentalg achieved a record turnover of €3.7 million, surpassing the previous year’s first-quarter record. This growth is attributed to a strategic pivot away from the low-margin aquaculture sector, targeting higher-margin segments like dietary supplements, resulting in a 42% sales increase.

The rise in fish oil prices has been significant, following a sharp decline in 2024 and stabilization in 2025. This presents an opportunity for Fermentalg's BioSolutions to substitute fish oils amid reduced fishing quotas and robust demand for omega-3 products.

Fermentalg is poised for further growth with the commercial launch of the ΩRIGINS™ EPA/DHA algal oil range and the natural blue colorant, Galdieria Blue, approved in the US and awaiting European marketing authorization.